Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 8,696.0 | 8,040.0 | 7,794.0 | 5,771.0 | 5,425.0 | 5,017.2 | 4,570.1 | 4,181.1 |
| Revenue growth | 8.2% | 3.2% | 35.1% | 6.4% | 8.1% | 9.8% | 9.3% | 10.1% |
| Cost of goods sold | 3,923.0 | 3,535.0 | 3,383.0 | 2,309.0 | 2,101.0 | 1,993.3 | 1,843.2 | 1,608.3 |
| Gross profit | 4,773.0 | 4,505.0 | 4,411.0 | 3,462.0 | 3,324.0 | 3,023.9 | 2,726.9 | 2,572.8 |
| Gross margin | 54.9% | 56.0% | 56.6% | 60.0% | 61.3% | 60.3% | 59.7% | 61.5% |
| Sales and marketing | 1,381.0 | 1,319.0 | 1,364.0 | 954.0 | 937.0 | 899.5 | 886.8 | 829.9 |
| Research and development | 265.0 | 263.0 | 280.0 | 123.0 | 112.0 | 82.1 | 64.4 | 62.8 |
| General and administrative | 514.0 | 511.0 | 524.0 | 354.0 | 335.0 | 341.1 | 324.8 | 293.9 |
| EBITA | 2,169.0 | 1,010.0 | 1,788.0 | 1,753.0 | 1,679.0 | 1,480.7 | 1,230.4 | 1,174.7 |
| EBITA margin | 24.9% | 12.6% | 22.9% | 30.4% | 30.9% | 29.5% | 26.9% | 28.1% |
| Amortization of intangibles | 154.0 | 152.0 | 141.0 | 23.0 | 38.0 | 48.5 | 51.7 | 55.0 |
| EBIT | 2,015.0 | 858.0 | 1,647.0 | 1,730.0 | 1,641.0 | 1,432.1 | 1,178.7 | 1,119.7 |
| EBIT margin | 23.2% | 10.7% | 21.1% | 30.0% | 30.2% | 28.5% | 25.8% | 26.8% |
| Pre-tax income | 1,526.0 | 430.0 | 1,197.0 | 1,421.0 | 1,264.0 | 1,091.7 | 892.0 | 830.8 |
| Income taxes | 212.0 | 299.0 | 283.0 | 245.0 | 616.0 | 345.7 | 382.2 | 337.5 |
| Tax rate | 13.9% | 69.5% | 23.6% | 17.2% | 48.7% | 31.7% | 42.9% | 40.6% |
| Net income | 1,314.0 | 131.0 | 914.0 | 1,176.0 | 648.0 | 745.9 | 509.7 | 493.2 |
| Net margin | 15.1% | 1.6% | 11.7% | 20.4% | 11.9% | 14.9% | 11.2% | 11.8% |
| |
| Diluted EPS | $0.32 | $0.03 | $0.20 | $0.26 | $0.14 | $0.15 | $0.09 | $0.08 |
| Shares outstanding (diluted) | 4,143.0 | 4,429.0 | 4,616.0 | 4,561.0 | 4,724.0 | 4,964.7 | 5,435.2 | 5,862.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|